CHINESE JOURNAL OF DRUG EVALUATION >

2025 , Vol. 42 >Issue 5: 356 - 356-360

DOI: https://doi.org/magtech-2024-10-14-00001

Study on the Determination and Influencing Factors of Hyoscyamine Sulfate and Scopolamine Lactone Content in Vitamin U Belladonna Aluminum Capsules Ⅱ

  • Di ZHANG
Expand
  • Liaoning Inspection， Examination and Certification Centre， Liaoning Institute for Drug Control/NMPA Key Laboratory for Quality
         Research and Evaluation of Chemical Drug， Liaoning Shenyang 110036， China

Received date: 2024-10-14

  Revised date: 2025-10-07

  Accepted date: 2025-11-27

  Online published: 2025-12-15

Fold

Abstract

Objective： To establish a method for determining the content of hyoscyamine sulfate and scopolamine lactone in Vitamin U Belladonna Aluminum Capsules Ⅱ， and to investigate the influence of influencing factors. Methods： High performance liquid chromatography was used for detection， with octadecylsilane bonded silica gel as the filler， 0.1 mol·L-1 sodium heptanesulfonate solution as the mobile phase A， methanol as the mobile phase B， gradient elution， flow rate of 1.0 mL·min-1， column temperature of 35 ℃， detection wavelengthes were set at 210 nm (asparagine sulfate) and 344 nm (Scopolamine lactone)， and injection volume of 100 μL. Results： The linear ranges of hyoscyamine sulfate and scopolamine lactone were 4.098-40.980 μg·mL-1 and 0.209 7-2.097 0 μg·mL-1， respectively， and the recovery rates were 100.3% and 100.7%， respectively (RSD of 1.9% and 2.8%， n=6). Hyoscyamine sulfate and Scopolamine lactone were unstable in hot environments， and their contents decreased more significantly with increasing temperature. Conclusion： The established method can accurately determine the content of hyoscyamine sulfate and scopolamine lactone in vitamin U belladonna aluminum capsules Ⅱ， with good specificity and simple pretreatment. The main factors affecting the content of sulfamethoxazole and scopolamine lactone were temperature and time. It was suggested that production enterprises should pay attention to controll the temperature and time of the drying process during the production process， and at the same time， control the storage conditions to avoid excessive temperature in the circulation process， which may cause product quality non-compliance.

Key words： ; font-size:medium; ">Vitamin U belladonna aluminum capsules Ⅱ； Content determination； Amanita sulfate； Scopolamine lactone； Influence factor

Cite this article

Di ZHANG . Study on the Determination and Influencing Factors of Hyoscyamine Sulfate and Scopolamine Lactone Content in Vitamin U Belladonna Aluminum Capsules Ⅱ[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025 , 42(5) : 356 -356-360 . DOI: magtech-2024-10-14-00001

References

  [1] 陈汉林，李发全，董鳞. 维U颠茄铝胶囊Ⅱ联合奥美拉唑治疗胃溃疡的临床研究[J]. 现代药物与临床，2019，34(8)：2482-2487.
     [2] 国家药典委员会. 国家药品监督管理局国家药品标准：化学药品地方标准上升国家标准(第十一册) [M]. 北京：国家药典委员会，2002： 57.
     [3] Farah MH，Samyelsson G. Pharmacologically active phenylpropanoids from Senra incana [J]. Planta Medica，1992，58(1)：14-18.
     [4] 褚子璇，卢敏，熊山. 东莨菪内酯的药理活性及药代动力学研究进展[J]. 化学研究，2019，30(4)：434-440.
     [5] 赵磊，孙艳涛，牛凤兰. HPLC法测定维U颠茄铝镁胶囊中硫酸阿托品含量[J]. 今日药学，2013，23(9)：576-577，583.
     [6] 李汉强，吴贵枝. 维U颠茄铝胶囊Ⅱ中颠茄提取物含量测法方的研究[J]. 化学工程与装备，2011，(7)：182-184.
     [7] 王迅，黄巧玲，张文婷. 基于多成分定量分析结合薄层色谱检查的颠茄流浸膏质量评价[J]. 中国现代应用药学，2020，37(2)：187-191.
     [8] 刘益庆. 高效液相法测定颠茄磺苄啶片中硫酸阿托品含量[J]. 北方药学，2016，13(2)：13-14.
     [9] 刘益庆，陈乃江. 高效液相色谱法测定维U颠茄铝镁片中硫酸阿托品含量[J]. 中国药业，2011，20(10)：35-36.
     [10] 杜晖，任静，郑妍. 高效液相色谱法同时测定莨菪浸膏片中的4种活性组分[J]. 安徽医药，2020，24(4)：674-676.
     [11] 吴雨川，于新颖，刘天扬，等. 维U颠茄铝胶囊中颠茄流浸膏HPLC鉴别方法的建立[J]. 黑龙江医药，2014，27(3)：483-485.
     [12] 王勇，杨秀荣，张丽，等. HPLC法同时测定白花蛇舌草中槲皮素和东莨菪内酯的含量[J]. 中国药师，2019，22(9)：1761-1763.
     [13] 徐犇，李纳，刘吉爽，等. 吉林省不同产地万年蒿中东莨菪内酯HPLC含量测定[J]. 长春中医药大学学报，2018，34(5)：880-883.
     [14] 苟保灵，汪鋆植，张宏岐，等. 水马桑4种不同部位中秦皮素、东莨菪内酯的测定[J]. 中成药，2018，40(11)：2560-2563.
     [15] 向鹏宇，陈健，吕紫璇，等. HPLC同时测定桑白皮中绿原酸、东莨菪内酯、白藜芦醇、桑色素4种成分的含量[J]. 北方药学，2018，15(7)：1-2.
     [16] 张迪，于明，李沫，等. 奥扎格雷钠氯化钠(葡萄糖)注射液评价性抽验结果及分析[J]. 中国药房，2014，25(21)：1976-1979.
Options
Outlines

/

〈 〉

[an error occurred while processing this directive]